drugset
drugset / Trial / NCT01348724

Absorption, Distribution, Metabolism and Excretion (ADME) Study With Single Oral Administration of [14C] NKTR-118

NCT01348724 ↗

Phase 1 Completed 6 enrolled AstraZeneca
CrossoverOpen-labelBasic science

Summary

Study to Assess the Absorption, Metabolism and Excretion of \[14C\] NKTR-118 after a Single-Dose Oral Administration.

Timeline

Start
2011-06
Primary completion
2011-09
Completion
2011-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Naloxegol Small molecule 25 mg Oral

Indications

No indication recorded.